Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relay Medical Corp. (C:RELA)

Business Focus: Medical Diagnostic & Testing Equipment

Log in or join to add this stock to your watch list.
Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEDAR
Company Contact
Address: 401 Bay St 16th Floor
TORONTO ON M5H 2Y4
Tel: N/A
Website: https://www.relaymedical.com
IR: See website
Key People
N/A    
Business Overview
Relay Medical Corp, formerly ChroMedX Corp, is a Canada-based medical technology company. The Company focuses on the development of handheld medical devices for In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). The Company's devices are protected by issued United States and pending international patents, in the medical diagnostics and research field, dealing with blood collection, analysis and plasma/serum processing. The Company has the following platform technologies: HemoPalm and Automated Ultra Filtration (AUF) technology. Its HemoPalm platform is a blood analysis system consisting of a handheld analyzer and a suite of disposable single use cartridges. Its UAF technology allows the preparation of ultra-filtrates of serum and plasma samples, for measurement of therapeutic drugs and hormones to be done on an automated system.
Financial Overview
For the six months ended 31 March 2019, Relay Medical Corp revenues was not reported. Net loss decreased 37% to C$2.6M. Lower net loss reflects Share-based compensation decrease from C$2.4M (expense) to C$0K, Shareholder communications and marketing decrease of 81% to C$52K (expense), Management fees decrease of 59% to C$50K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.05 to -C$0.02.
Reporting Currency: Canadian Dollars
Enterprise value: $19.21M as of Mar 31, 2019
Annual revenue (TTM): $0.00M as of Mar 31, 2019
EBITDA (TTM): -$5.34M as of Mar 31, 2019
Net annual income (TTM): -$6.62M as of Mar 31, 2019
Free cash flow (TTM): -$4.76M as of Mar 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 113,187,191 as of Mar 31, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization